These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 1317906)
61. Release of tissue-type plasminogen activator in response to muscarinic receptor stimulation in human forearm. Jern S; Selin L; Bergbrant A; Jern C Thromb Haemost; 1994 Oct; 72(4):588-94. PubMed ID: 7878638 [TBL] [Abstract][Full Text] [Related]
62. Pattern of peripheral venous response to volume expansion in borderline systemic hypertension. Borghi C; Boschi S; Costa FV; Ambrosioni E Am J Cardiol; 1990 Sep; 66(5):597-602. PubMed ID: 2144096 [TBL] [Abstract][Full Text] [Related]
63. Effects of norepinephrine and angiotensin II on plasma atrial natriuretic peptide concentration in humans. Shimamoto K; Nakagawa M; Fukuyama S; Ura N; Murakami H; Yonekura S; Iwakura M; Yamaguchi Y; Ise T; Saitoh S J Cardiovasc Pharmacol; 1989; 13 Suppl 6():S59-62. PubMed ID: 2473353 [TBL] [Abstract][Full Text] [Related]
64. Renal effects of prolonged intrarenal infusions of angiotensin II and atrial natriuretic peptide in sheep. Fan L; Mukaddam-Daher S; Javeshghani D; Quillen E; Gutkowska J J Cardiovasc Pharmacol; 1999 Sep; 34(3):427-33. PubMed ID: 10471003 [TBL] [Abstract][Full Text] [Related]
65. Calculation of plasma concentrations of intra-arterially infused compounds in forearm plethysmography. Bruning TA; Kemme MJ; Chang PC; Muizert Y; van Zwieten PA Cardiovasc Res; 1998 Jan; 37(1):210-5. PubMed ID: 9539875 [TBL] [Abstract][Full Text] [Related]
66. Renal effects of atrial natriuretic peptide during dopamine infusion. Hirata Y; Fukui K; Hayakawa H; Suzuki E; Sugimoto T; Kimura K; Matsuoka H; Sugimoto T Am J Hypertens; 1990 Nov; 3(11):866-9. PubMed ID: 2175625 [TBL] [Abstract][Full Text] [Related]
67. Hemodynamic effects of human atrial natriuretic peptide after modified Fontan procedure. Hiramatsu T; Imai Y; Takanashi Y; Seo K; Terada M; Nakazawa M Ann Thorac Surg; 1998 Mar; 65(3):761-4. PubMed ID: 9527208 [TBL] [Abstract][Full Text] [Related]
68. Inhibition of prostaglandin synthesis does not alter the decrease in pre-capillary resistance in the human calf in response to small cumulative increases in venous congestion. Anderson SI; Brown MD Clin Sci (Lond); 2005 Sep; 109(3):303-9. PubMed ID: 15898957 [TBL] [Abstract][Full Text] [Related]
69. Forearm venous distensibility predicts successful arteriovenous fistula. van der Linden J; Lameris TW; van den Meiracker AH; de Smet AA; Blankestijn PJ; van den Dorpel MA Am J Kidney Dis; 2006 Jun; 47(6):1013-9. PubMed ID: 16731296 [TBL] [Abstract][Full Text] [Related]
70. ANP-mediated volume depletion attenuates renal responses in humans. Ebert TJ; Groban L; Muzi M; Hanson M; Cowley AW Am J Physiol; 1992 Dec; 263(6 Pt 2):R1303-8. PubMed ID: 1481943 [TBL] [Abstract][Full Text] [Related]
71. Cardiac and vascular effects of atrial natriuretic factor and sodium nitroprusside in healthy men. Roy LF; Ogilvie RI; Larochelle P; Hamet P; Leenen FH Circulation; 1989 Feb; 79(2):383-92. PubMed ID: 2536599 [TBL] [Abstract][Full Text] [Related]
72. Atrial natriuretic factor as a vasodilator agent in hypertensive patients. Pedrinelli R; Spessot M; Panarace G; Taddei S; Favilla S; Salvetti A Am J Med Sci; 1990 Aug; 300(2):78-82. PubMed ID: 2144948 [TBL] [Abstract][Full Text] [Related]
73. Calcitonin gene-related peptide-induced vasodilation in the human forearm is antagonized by CGRP8-37: evaluation of a human in vivo pharmacodynamic model. Vanmolkot FH; Van der Schueren BJ; de Hoon JN Clin Pharmacol Ther; 2006 Mar; 79(3):263-73. PubMed ID: 16513450 [TBL] [Abstract][Full Text] [Related]
74. Plasma levels of atrial natriuretic peptide and brain natriuretic peptide following intravenous saline infusion in oedematous chronic obstructive pulmonary disease and non-oedematous chronic obstructive pulmonary disease. Sheedy W; Stewart AG; Morice AH Respiration; 1996; 63(6):376-80. PubMed ID: 8933657 [TBL] [Abstract][Full Text] [Related]
75. [Does atrial antipressor natriuretic peptide play a pathophysiological role?]. Bühler FR Schweiz Med Wochenschr; 1987 Dec; 117(49):1930-7. PubMed ID: 2962281 [TBL] [Abstract][Full Text] [Related]
77. Modulation of the natriuretic response to atrial natriuretic peptide by alterations in peritubular Starling forces in the rat. Mendez RE; Dunn BR; Troy JL; Brenner BM Circ Res; 1986 Dec; 59(6):605-11. PubMed ID: 2949885 [TBL] [Abstract][Full Text] [Related]
78. The effects of atrial natriuretic peptide infusion on hemodynamic, renal, and hormonal responses during gastrectomy. Shirakami G; Segawa H; Shingu K; Saito Y; Magaribuchi T; Nakao K; Mori K Anesth Analg; 1997 Oct; 85(4):907-12. PubMed ID: 9322478 [TBL] [Abstract][Full Text] [Related]
79. Prostacyclin counteracts the increase in capillary permeability induced by tumour necrosis factor-alpha. Jahr J; Grände PO Intensive Care Med; 1996 Dec; 22(12):1453-60. PubMed ID: 8986503 [TBL] [Abstract][Full Text] [Related]
80. [Effects of lidocaine on arterial and venous circulation of limbs in man]. Edouard A; Probst D; Duranteau J; Tarot JP; Pussard E Ann Fr Anesth Reanim; 1991; 10(6):529-34. PubMed ID: 1785702 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]